EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Plasma miR-145-5p levels and risk of cancer-associated thrombosis—results from the HUNT study

Christopher Antoun, Julia Oto, Raquel Herranz, Pilar Medina, Vania M Morelli, Kristian Hveem, Sigrid K Brækkan, John-Bjarne Hansen

Journal of Thrombosis and Haemostasis · 2026

DOI: 10.1016/j.jtha.2025.12.024 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Thrombosis and Haemostasis, 2026. Verfasst von Christopher Antoun und 7 weiteren Autor:innen. Beteiligte Einrichtung: Thrombosis Research Group (TREC), Department of Clinical Medicine, UiT-The Arctic University of Norway, Tromsø, Norway. Electronic address: christoph…. Hauptthemen laut MEDLINE: MicroRNAs, Neoplasms, Venous Thromboembolism, Circulating MicroRNA. Die Arbeit nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Stiftelsen Kristian Gerhard Jebsen.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: The incidence of cancer-associated venous thromboembolism (CAT) has risen in recent decades, underscoring the need for novel risk biomarkers and mechanistic insights. MicroRNAs (miRNAs) have emerged as promising biomarkers for various diseases, with elevated miRNA-145-5p (miR-145-5p) levels linked to reduced venous thromboembolism (VTE) risk. We aimed to investigate the association between plasma miR-145-5p levels and risk of future VTE related to (CAT) and unrelated to cancer (non-CAT). METHODS: Plasma miR-145-5p levels were measured in a case cohort derived from the Trøndelag Health Study (HUNT3; N = 50 807). The study included 455 VTEs (95 CATs), occurring during 9 years of follow-up, and 1740 randomly sampled age-weighted subcohort participants. VTEs were classified as CAT if they occurred within 1 year before or 2 years after a cancer diagnosis. Multivariable adjusted hazard ratios (HRs) for CAT and non-CAT were estimated using weighted Cox regression, with cancer modeled as a time-varying covariate. RESULTS: Increasing miR-145-5p levels were associated with lower risk of CAT (HR per 1 SD, 0.70; 95% CI, 0.52-0.96) and non-CAT (HR, 0.81; 95% CI, 0.72-0.91). Individuals in the highest miR-145-5p quartile had lower risk of both CAT (HR, 0.55; 95% CI, 0.25-1.20) and non-CAT (HR, 0.48; 95% CI, 0.33-0.69) than those in the lowest quartile. CONCLUSIONS: High plasma miR-145-5p levels were associated with lower risk of CAT and non-CAT, suggesting that miR-145-5p has the potential to serve as a risk biomarker for CAT.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MicroRNAsNeoplasmsVenous ThromboembolismCirculating MicroRNAHumansFemaleRisk FactorsMaleMiddle AgedAgedProportional Hazards ModelsNorwayTime FactorsIncidenceMultivariate AnalysisAdultRisk Assessment

Stichwörter der Autor:innen

biomarkercancercohort studiesmicroRNAsvenous thromboembolism

Substanzen

MicroRNAsMIRN145 microRNA, humanCirculating MicroRNA

Autor:innen und Institutionen

  • Thrombosis Research Group (TREC), Department of Clinical Medicine, UiT-The Arctic University of Norway, Tromsø, Norway. Electronic address: christopher.antoun@uit.no.
  • Haemostasis, Thrombosis, Arteriosclerosis and Vascular Biology Research Group, Health Research Institute Hospital La Fe (IIS La Fe), Valencia, Spain.
  • Thrombosis Research Group (TREC), Department of Clinical Medicine, UiT-The Arctic University of Norway, Tromsø, Norway; Thrombosis Research Center (TREC), Division of Internal Medicine, University Hospital of North Norw…
  • Department of Public Health and Nursing, Faculty of Medicine and Health Sciences, HUNT Research Center for Molecular and Clinical Epidemiology, Norwegian University of Science and Technology, Trondheim, Norway; Departme…

Förderung

  • Stiftelsen Kristian Gerhard Jebsen

Zitieren

APA

Antoun, C., Oto, J., Herranz, R., Medina, P., Morelli, V. M., Hveem, K., Brækkan, S. K., & Hansen, J. B. (2026). Plasma miR-145-5p levels and risk of cancer-associated thrombosis—results from the HUNT study. Journal of Thrombosis and Haemostasis. https://doi.org/10.1016/j.jtha.2025.12.024

Vancouver

Antoun C, Oto J, Herranz R, Medina P, Morelli VM, Hveem K, et al. Plasma miR-145-5p levels and risk of cancer-associated thrombosis—results from the HUNT study. Journal of Thrombosis and Haemostasis. 2026. doi:10.1016/j.jtha.2025.12.024

BibTeX
@article{Antoun2026,
  author = {Antoun, Christopher and Oto, Julia and Herranz, Raquel and Medina, Pilar and Morelli, Vania M and Hveem, Kristian and Brækkan, Sigrid K and Hansen, John-Bjarne},
  title = {Plasma miR-145-5p levels and risk of cancer-associated thrombosis—results from the HUNT study},
  journal = {Journal of Thrombosis and Haemostasis},
  year = {2026},
  doi = {10.1016/j.jtha.2025.12.024}
}
Kostenlos starten →